Skip to search.
 TSX Up 0.24% TSX Ventures Up 0.49%

Novavax, Inc. (NVAX)

-NasdaqGS
7.35 Down 0.09(1.21%) Jul 22, 4:00PM EDT
|After Hours : 7.35 0.00 (0.00%) Jul 22, 5:01PM EDT
Prev Close:7.44
Open:7.38
Bid:7.29 x 2000
Ask:7.34 x 100
1y Target Est:14.21
Beta:1.95124
Earnings Date:Aug 8 - Aug 12 (Est.)
Day's Range:7.15 - 7.41
52wk Range:4.08 - 15.01
Volume:5,917,290
Avg Vol (3m):5,178,420
Market Cap:1.99B
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXDown 1.21%1.99B
MRKUp 0.05%162.82B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):65.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.96
Quarterly EPS Est (Jun-16) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback